The serum pepsinogen test as a predictor of gastric cancer: The Hisayama study

American Journal of Epidemiology

Volumn 163, Issue 7, 2006, Pages 629-637

  Oishi, Yoshinori ^a   Kiyohara, Yutaka ^a   Kubo, Michiaki ^a   Tanaka, Keiichi ^a   Tanizaki, Yumihiro ^a   Ninomiya, Toshiharu ^a   Doi, Yasufumi ^a   Shikata, Kentaro ^a   Yonemoto, Koji ^a   Shirota, Tomoko ^b   Matsumoto, Takayuki ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

Cohort studies; Gastritis, atrophic; Helicobacter pylori; Pepsinogens; Stomach neoplasms

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

CANCER;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CLINICAL EXAMINATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE; MAJOR CLINICAL STUDY; MALE; POPULATION; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STOMACH CANCER; TIME SERIES ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PEPSINOGENS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 33645306583     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj088     Document Type: Article

References (44)

1. Samloff IM. Immunologic studies of human group I pepsinogens. J Immunol 1971;106:962-8.
2. Samloff IM. Pepsinogens, pepsins, and pepsin inhibitors. Gastroenterology 1971;60:586-604.
3. Hirschowitz BI. Pepsinogen: its origins, secretion and excretion. Physiol Rev 1957;37:475-511.
4. Samloff IM, Varis K, Ihamaki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
5. Miki K, Ichinose M, Shimizu A, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41.
6. Correa P. The epidemiology of gastric cancer. World J Surg 1991;15:228-34.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
8. Nomura AM, Stemmermann GN, Samloff IM. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980;93:537-40.
9. Ellis A, Hughes S, McConnell RB. Gastric neoplasms and pepsinogen phenotypes. Br J Cancer 1982;46:289-90.
10. Miki K, Ichinose M, Kawamura N, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989;80:111-14.
11. Webb PM, Hengels KJ, Moller H, et al. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology 1994;107:1335-44.
12. Kikuchi S, Wada O, Miki K, et al. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1994;73:2695-702.
13. Fukuda H, Saito D, Hayashi S, et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 1995;86:64-71.
14. Kodoi A, Yoshihara M, Sumii K, et al. Serum pepsinogen in screening for gastric cancer. J Gastroenterol 1995;30:452-60.
15. Parsonnet J, Samloff IM, Nelson LM, et al. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1993;2:461-6.
16. Aromaa A, Kosunen TU, Knekt P, et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996;144:142-9.
17. Watanabe Y, Kurata JH, Mizuno S, et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 1997;42:1383-7.
18. Nomura AM, Stemmermann GN, Chyou PH. Gastric cancer among the Japanese in Hawaii. Jpn J Cancer Res 1995;86:916-23.
19. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43.
20. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-8.
21. Miki K, Ichinose M, Ishikawa KB, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84:1086-90.
22. Kitahara F, Kobayashi K, Sato T, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999;44:693-7.
23. Miki K, Morita M, Sasajima M, et al. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003;98:735-9.
24. Kiyohira K, Yoshihara M, Ito M, et al. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol 2003;38:332-8.
25. Yamagata H, Kiyohara Y, Aoyagi K, et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med 2000;160:1962-8.
26. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
27. Ohmura T, Ueda K, Kiyohara Y, et al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study. Diabetologia 1993;36:1198-203.
28. The Ministry of Health and Welfare of Japan. The Results of the National Nutrition Survey in 1989. (In Japanese). Tokyo, Japan: Dai-Ichi Shuppan Publishing Co Ltd, 1991.
29. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
30. Ichinose M, Miki K, Furihata C, et al. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982;126:183-91.
31. Shirota T, Yoshizumi E. Accuracy of nutritional survey using the simple method. (In Japanese). Jpn J Public Health 1990;37:100-8.
32. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
33. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972;34:187-202.
34. SAS/STAT user's guide, version 8. Cary, NC: SAS Institute, Inc, 1999.
35. Kneller RW, You WC, Chang YS, et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst 1992;84:1261-6.
36. Kato I, Vivas J, Plummer M, et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 2004;13:468-76.
37. Chen VW, Abu-Elyazeed RR, Zavala DE, et al. Risk factors of gastric precancerous lesions in a high-risk Colombian population. I. Salt. Nutr Cancer 1990;13:59-65.
38. Bergin IL, Sheppard BJ, Fox JG. Helicobacter pylori infection and high dietary salt independently induce atrophic gastritis and intestinal metaplasia in commercially available outbred Mongolian gerbils. Dig Dis Sci 2003;48:475-85.
39. Nardone G. Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 2003;17(suppl 2):75-81.
40. Kokkola A, Kosunen TU, Puolakkainen P, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-24.
41. Sipponen P, Kekki M, Haapakoski J, et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7.
42. Furukawa H, Iwanaga T, Koyama H, et al. Effect of sex hormones on the experimental induction of cancer in rat stomach - a preliminary study. Digestion 1982;23:151-5.
43. Hattori Y, Tashiro H, Kawamoto T, et al. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens. Jpn J Cancer Res 1995;86:1210-15.
44. Hisamichi S. Screening for gastric cancer. World J Surg 1989;13:31-7.